Giant Biogene Holding Co., Ltd.
2367
Rank in Stocks
#5025
Giant Biogene Holding Co., Ltd. operates as an investment holding entity,... Giant Biogene Holding Co., Ltd. operates as an investment holding entity, primarily engaged in the research, development, production, and sale of beauty and wellness products based on bioactive materials throughout the People's Republic of China. The company also manufactures functional foods leveraging rare ginsenosides technology and provides medical devices. Its diverse product range, which includes specialized skincare, medical dressings, and nutritional supplements, is marketed predominantly under brand names such as Comfy, Collgene, Keyu, Kehen, Kefuping, Leeyen, SKIGIN, and Shengan. Established in 2000, Giant Biogene Holding Co., Ltd. maintains its headquarters in Xi'an, PRC.
Share Price
$2.67
Market Cap
$2.84B
Change (1 day)
-6.09%
Change (1 year)
-46.20%
Country
CN
Trade Giant Biogene Holding Co., Ltd. (2367)
Category
Consumer Defensive
P/B ratio for Giant Biogene Holding Co., Ltd. (2367)
P/B ratio as of October 2026 TTM: 2.00
According to Giant Biogene Holding Co., Ltd. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 2.00. At the end of 2024 the company had a P/B ratio of 6.60.
P/B ratio history for Giant Biogene Holding Co., Ltd. from 2019 to 2026
P/B ratio at the end of each year
| Year | P/B Ratio | Change |
|---|---|---|
| 2026 (TTM) | 2.00 | -37.21% |
| 2025 | 3.19 | -51.68% |
| 2024 | 6.60 | -9.00% |
| 2023 | 7.25 | -29.02% |
| 2022 | 10.22 | -50.98% |
| 2021 | 20.85 | -57.14% |
| 2020 | 48.63 | 136.00% |
| 2019 | 20.61 | 0.00% |
P/B ratio for similar companies or competitors
| Company | P/B Ratio | P/B Ratio Difference | Country |
|---|---|---|---|
| 6.9837 | 248.68% |
US
|
|
| 6.3772 | 218.40% |
FR
|
|
| 315.2455 | 15,639.45% |
US
|
|
| 9.0934 | 354.01% |
IN
|
|
| 9.8894 | 393.75% |
US
|
